Dr Lalchandani Labs Ltd — Important, 16-01-2026: Company Update

Dr Lalchandani Labs Ltd. has secured in-principal approval from BSE Limited for its upcoming rights issue. This signifies a major step forward in the company's plan to raise capital by offering new equity shares to its current shareholders. The shares will have a face value of Rs. 10 each. This capital infusion is vital for the company's operational growth or financial strengthening. Shareholders should note that this approval paves the way for them to potentially subscribe to new shares and increase their stake.